What is Omega Healthcare Investors Inc.'s earnings per share (EPS)?

Omega Healthcare Investors Inc. (OHI) reported diluted earnings per share of $1.94 for fiscal year 2025. This represents a 25.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Omega Healthcare Investors Inc. (OHI) Financials

OHI

Trailing 12 months to June 30, 2026

Revenue $1.3B +15.0% YoY

Net Income $268.9M +314.7% YoY

EPS (Diluted) $2.80 +72.8% YoY

Operating Cash Flow $890.6M +6.6% YoY

Market Cap $13.5B as of Oct 10, 2026

Price / Sales 10.5x on $1.3B revenue, trailing 12 months to June 30, 2026

Price / Earnings 50.1x on $268.9M net income, trailing 12 months to June 30, 2026

Price / Book 2.5x on $5.4B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 30, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the OHI SEC filings page.

Omega Healthcare Investors Inc. (OHI) reported $1.3B in revenue over the twelve months to Jun 30, 2026, up 15.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI OHI FY2025 2026-10-03

The reported profile is a balance-sheet-led investment vehicle, with falling leverage and cash generation rising faster than reported earnings.

Cash generation and reported earnings diverge sharply: operating cash flow reached $878.6M in FY2025 while reported net income was only $609K. That gap means the income statement alone does not capture the main economics reflected in the reported cash flows.

The balance sheet became less debt-dependent: total liabilities fell from $5.2B in FY2024 to $4.6B in FY2025, while total assets increased to $10.0B. This combination points to a larger equity-funded asset base rather than growth financed primarily through additional liabilities.

Reported operating cash flow rose from $617.7M in FY2023 to $878.6M in FY2025, alongside long-term debt declining to $4.3B. The pattern suggests that cash generation was increasingly available alongside balance-sheet deleveraging, even as the reported earnings measure remained unusually small relative to the asset base.

Financial Health Signals

Financial Health Score 26/100

Scored as: REITs peer group

Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Omega Healthcare Investors Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

FFO Margin

FFO Margin measures funds from operations against revenue, and funds from operations is net income with property depreciation added back, since a building written down a little further every year on paper is often worth more rather than less. Omega Healthcare Investors Inc. scores 56/100 on it among other REITs.

FFO Growth

FFO Growth follows the three-year path of funds from operations, which is net income with property depreciation added back. Omega Healthcare Investors Inc. scores 26/100 on it among other REITs.

Leverage

Not available for Omega Healthcare Investors Inc., and counted as zero in the overall score.

Interest Cov.

Not available for Omega Healthcare Investors Inc., and counted as zero in the overall score.

AFFO Margin

AFFO Margin takes funds from operations, subtracts the spending a REIT needs just to keep its properties in working order, and measures what is left against revenue. Omega Healthcare Investors Inc. scores 59/100 on it among other REITs.

Dividend Cov.

Dividend coverage measures funds from operations against the dividends actually paid, and a figure above 1 means the payout came out of operations. Omega Healthcare Investors Inc. scores 12/100 on it among other REITs.

Piotroski F-Score Partial

6/7

Omega Healthcare Investors Inc. passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

N/A

Omega Healthcare Investors Inc. reported $609K of net income while generating $878.6M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$328.2M

YoY+16.2%

QoQ+1.6%

5Y CAGR+5.0%

Omega Healthcare Investors Inc. generated $328.2M in revenue in Q2 2026. This represents an increase of 16.2% from the same quarter a year earlier. Against the prior quarter it is up 1.6%.

EBITDA

$412.8M

YoY+14.1%

Omega Healthcare Investors Inc.'s EBITDA was $412.8M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 14.1% from the same quarter a year earlier.

Net Income

$362.8M

YoY+165.6%

QoQ+140.2%

5Y CAGR+33.1%

10Y CAGR+12.9%

Omega Healthcare Investors Inc. reported $362.8M in net income in Q2 2026. This represents an increase of 165.6% from the same quarter a year earlier. Against the prior quarter it is up 140.2%.

EPS (Diluted)

$1.19

YoY+158.7%

QoQ+153.2%

5Y CAGR+27.0%

10Y CAGR+7.6%

Omega Healthcare Investors Inc. earned $1.19 per diluted share (EPS) in Q2 2026. This represents an increase of 158.7% from the same quarter a year earlier. Against the prior quarter it is up 153.2%.

Cash & Balance Sheet

Cash & Debt

$39.0M

YoY-94.7%

QoQ+49.3%

5Y CAGR-17.3%

10Y CAGR+1.7%

Omega Healthcare Investors Inc. held $39.0M in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share

$0.67

YoY0.0%

QoQ0.0%

5Y CAGR0.0%

10Y CAGR+1.5%

Omega Healthcare Investors Inc. paid $0.67 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

303M

YoY+2.7%

QoQ+1.7%

5Y CAGR+4.9%

Omega Healthcare Investors Inc. had 303M shares outstanding in Q2 2026. This represents an increase of 2.7% from the same quarter a year earlier. Against the prior quarter it is up 1.7%.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Return on Equity

6.7%

YoY+4.0pp

QoQ+3.8pp

5Y change+4.6pp

10Y change+3.8pp

Omega Healthcare Investors Inc.'s ROE was 6.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 4.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not shown for Q2 2026: the reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q2 2026: the reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

None of these metrics is reported for Q2 2026.

OHI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OHI quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.3B	$1.2B+13.2%	$1.1B+10.7%	$949.7M+8.1%	$878.2M-17.4%	$1.1B+19.1%	$892.4M-3.9%	$928.8M+5.3%	$881.7M-2.9%	$908.4M+0.8%	$900.8M	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$116.8M	$104.1M+18.3%	$88.0M+8.0%	$81.5M+17.4%	$69.4M+7.4%	$64.6M+7.9%	$59.9M+3.5%	$57.9M-8.9%	$63.5M+33.2%	$47.7M+4.0%	$45.9M+18.9%	$38.6M+49.0%	$25.9M+19.9%	$21.6M+1.2%	$21.3M+9.8%	$19.4M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$551.7M+10.9%	$497.6M+57.9%	$315.2M-43.7%	$560.0M+36.2%	$411.3M+19.1%	$345.3M+30.0%	$265.7M+23.6%	$215.0M+56.0%	$137.8M
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$853.4M+9.6%	$778.9M+29.2%	$602.8M-27.1%	$827.0M+33.0%	$622.0M+32.7%	$468.6M+18.8%	$394.3M+20.2%	$327.9M+37.7%	$238.1M
Interest Expense	$207.7M	$215.0M-3.0%	$221.7M-5.9%	$235.5M+1.0%	$233.2M-0.6%	$234.6M+5.0%	$223.4M+7.0%	$208.7M+8.4%	$192.5M+2.0%	$188.8M+15.0%	$164.1M+11.3%	$147.4M+23.5%	$119.4M+18.9%	$100.4M+5.1%	$95.5M+17.7%	$81.2M
Income Tax	$16.3M	$14.7M+35.8%	$10.9M+73.6%	$6.3M+37.1%	$4.6M+18.8%	$3.8M-22.0%	$4.9M+73.2%	$2.8M-5.5%	$3.0M-7.3%	$3.2M+131.2%	$1.4M+16.0%	$1.2M	N/A	N/A	N/A	N/A
Net Income	$268.9M	$609K+45.9%	$418K+67.9%	$249K-43.3%	$439K+2.5%	$428K-99.7%	$163.5M-53.5%	$351.9M+19.8%	$293.9M+180.1%	$104.9M-72.6%	$383.4M+64.3%	$233.3M+5.4%	$221.3M+28.3%	$172.5M+42.9%	$120.7M+129.4%	$52.6M
EPS (Basic)	N/A	$1.96+24.8%	$1.57+55.4%	$1.01-44.2%	$1.81+2.8%	$1.76+151.4%	$0.70-56.3%	$1.60+13.5%	$1.41+176.5%	$0.51-73.3%	$1.91+46.9%	$1.30-25.7%	$1.75+19.0%	$1.47+31.2%	$1.12+143.5%	$0.46
EPS (Diluted)	$2.80	$1.94+25.2%	$1.55+55.0%	$1.00-44.4%	$1.80+2.9%	$1.75	$0.70-55.7%	$1.58+12.9%	$1.40+174.5%	$0.51-73.2%	$1.90+47.3%	$1.29-25.9%	$1.74+19.2%	$1.46+30.4%	$1.12+143.5%	$0.46
Diluted Shares (Avg)	N/A	305M+12.8%	270M+8.0%	250M+2.5%	244M0.0%	244M	235M+5.8%	222M+5.9%	210M+1.4%	207M+2.6%	202M+11.7%	181M+41.8%	127M+107684.9%	118,100-99.9%	108M+5.7%	102M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$328.2M+16.2%	$323.0M+16.7%	$319.2M+14.3%	$311.6M+12.9%	$282.5M+11.8%	$276.8M+13.8%	$279.3M+16.7%	$276.0M+14.0%
SG&A Expenses	$42.0M+80.1%	$26.0M-18.8%	$25.0M+10.7%	$23.8M+9.3%	$23.3M+5.3%	$32.1M+48.9%	$22.6M+21.7%	$21.8M+7.3%
Operating Income	$330.9M+17.7%	N/A	N/A	N/A	$281.2M	N/A	N/A	N/A
EBITDA	$412.8M+14.1%	N/A	N/A	N/A	$361.7M	N/A	N/A	N/A
Interest Expense	$48.1M-9.0%	$49.8M-4.8%	$51.7M-6.3%	$58.1M+6.3%	$52.9M-2.0%	$52.3M-9.6%	$55.2M-7.0%	$54.7M-7.0%
Income Tax	$4.6M+2.0%	$5.1M+41.4%	$2.1M-28.7%	$4.5M+35.2%	$4.5M+128.7%	$3.6M+39.9%	$3.0M-28.4%	$3.3M+88.6%
Net Income	$362.8M+165.6%	$151.0M+38.5%	-$424.7M-45.2%	$179.7M+60.8%	$136.6M+20.0%	$109.0M+61.9%	-$292.6M-52.4%	$111.8M+19.0%
EPS (Basic)	$1.21+163.0%	$0.47+38.2%	$0.55+34.1%	$0.60+39.5%	$0.460.0%	$0.34+25.9%	$0.41+78.3%	$0.43+16.2%
EPS (Diluted)	$1.19+158.7%	$0.47+42.4%	$0.55+34.1%	$0.59+40.5%	$0.46+2.2%	$0.33+22.2%	$0.41+86.4%	$0.42+13.5%
Diluted Shares (Avg)	316M+4.3%	315M+6.8%	N/A	308M+11.8%	303M+15.9%	295M+14.6%	N/A	276M+7.7%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

OHI Balance Sheet

OHI quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$10.0B+1.5%	$9.9B+8.6%	$9.1B-3.1%	$9.4B-2.4%	$9.6B+1.5%	$9.5B-3.0%	$9.8B+14.0%	$8.6B-2.1%	$8.8B-2.0%	$8.9B+12.0%	$8.0B+103.7%	$3.9B+13.3%	$3.5B+16.1%	$3.0B+16.6%	$2.6B
Cash & Equivalents	$27.0M-94.8%	$518.3M+17.1%	$442.8M+49.0%	$297.1M+1346.9%	$20.5M-87.4%	$163.5M+578.1%	$24.1M+134.1%	$10.3M-88.0%	$85.9M-8.3%	$93.7M+1627.3%	$5.4M+20.8%	$4.5M+71.6%	$2.6M+52.9%	$1.7M+387.5%	$351K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$644.6M+0.1%	$643.7M0.0%	$643.9M+0.1%	$643.2M-1.3%	$651.4M0.0%	$651.7M+1.1%	$644.4M+0.1%	$644.0M-0.1%	$644.7M+0.2%	$643.5M-0.3%	$645.7M	N/A	N/A	N/A	N/A
Total Liabilities	$4.6B-10.8%	$5.2B-3.5%	$5.4B-4.4%	$5.6B+1.3%	$5.5B+1.3%	$5.5B0.0%	$5.5B+13.1%	$4.8B-1.2%	$4.9B+3.1%	$4.7B+21.8%	$3.9B+54.3%	$2.5B+16.6%	$2.2B+9.7%	$2.0B+17.4%	$1.7B
Long-Term Debt	$4.3B-12.0%	$4.8B-4.5%	$5.1B-4.2%	$5.3B+0.6%	$5.3B+1.6%	$5.2B+0.6%	$5.1B+13.1%	$4.5B-0.7%	$4.6B+4.7%	$4.4B+22.4%	$3.6B+50.1%	$2.4B+17.5%	$2.0B+10.9%	$1.8B+17.6%	$1.6B
Total Equity	$5.2B+14.2%	$4.5B+26.9%	$3.6B-1.0%	$3.6B-7.6%	$3.9B+1.7%	$3.8B-7.1%	$4.1B+20.1%	$3.4B-3.1%	$3.6B-7.9%	$3.9B+3.2%	$3.7B+166.7%	$1.4B+7.8%	$1.3B+28.6%	$1.0B+15.1%	$878.5M
Retained Earnings	$4.7B+14.4%	$4.1B+11.0%	$3.7B+7.0%	$3.4B+14.2%	$3.0B+16.1%	$2.6B+5.3%	$2.5B+15.6%	$2.1B+15.8%	$1.8B+5.8%	$1.7B+26.7%	$1.4B+19.6%	$1.1B+23.9%	$926.6M+22.9%	$754.1M+19.1%	$633.4M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$10.0B-5.0%	$10.2B+5.4%	$10.0B+1.5%	$10.6B+10.7%	$10.5B+19.2%	$9.7B+7.7%	$9.9B+8.6%	$9.6B+1.6%
Cash & Equivalents	$39.0M-94.7%	$26.1M-92.9%	$27.0M-94.8%	$737.2M+115.3%	$734.2M+1986.2%	$368.0M+1.7%	$518.3M+17.1%	$342.4M-38.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$644.4M-0.1%	$644.4M0.0%	$644.6M+0.1%	$644.6M0.0%	$644.9M+0.2%	$644.1M0.0%	$643.7M0.0%	$644.6M+0.2%
Total Liabilities	$4.4B-18.4%	$4.8B+0.1%	$4.6B-10.8%	$5.4B+3.5%	$5.4B+8.3%	$4.8B-10.1%	$5.2B-3.5%	$5.2B-7.1%
Long-Term Debt	N/A	N/A	$4.3B-12.0%	$5.0B+2.8%	$5.0B+7.3%	$4.4B-11.6%	$4.8B-4.5%	$4.9B-8.2%
Total Equity	$5.4B+8.1%	$5.2B+9.5%	$5.2B+14.2%	$5.0B+19.7%	$5.0B+34.4%	$4.7B+34.9%	$4.5B+26.9%	$4.2B+14.7%
Retained Earnings	$5.2B+19.8%	$4.8B+15.1%	$4.7B+14.4%	$4.5B+13.6%	$4.3B+12.2%	$4.2B+12.0%	$4.1B+11.0%	$4.0B+9.6%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.

OHI Cash Flow Statement

OHI quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$890.6M	$878.6M+17.2%	$749.4M+21.3%	$617.7M-1.3%	$625.7M-13.4%	$722.1M+2.0%	$708.3M+27.9%	$553.7M+10.9%	$499.4M-13.6%	$577.9M-7.5%	$624.8M+34.7%	$463.9M+37.4%	$337.5M+20.6%	$279.9M+34.4%	$208.3M+22.7%	$169.8M
Depreciation & Amortization	N/A	$325.2M+6.8%	$304.6M-4.7%	$319.7M-3.8%	$332.4M-2.8%	$342.0M+3.7%	$329.9M+9.4%	$301.7M+7.3%	$281.3M-2.2%	$287.6M+7.7%	$267.1M+26.7%	$210.7M+70.9%	$123.3M-4.2%	$128.6M+13.9%	$113.0M+12.6%	$100.3M
Stock-Based Compensation	N/A	$44.2M+20.4%	$36.7M+4.6%	$35.1M+28.4%	$27.3M+27.5%	$21.4M+13.8%	$18.8M+22.5%	$15.4M-3.9%	$16.0M+5.1%	$15.2M+10.3%	$13.8M+23.9%	$11.1M+29.6%	$8.6M+44.6%	$5.9M0.0%	$5.9M-1.6%	$6.0M
Investing Cash Flow	$186.5M	-$539.8M+19.6%	-$671.2M-87064.2%	-$770K-100.2%	$442.9M+184.5%	-$524.2M-488.6%	-$89.1M+76.5%	-$379.0M-118.8%	-$173.2M+39.2%	-$285.1M+74.4%	-$1.1B-180.3%	-$397.4M+27.5%	-$547.9M+8.5%	-$598.8M-53.3%	-$390.7M-51.6%	-$257.6M
Financing Cash Flow	-$1.7B	-$838.3M-3285.0%	$26.3M+105.6%	-$473.3M+40.0%	-$789.4M-131.4%	-$341.1M+29.7%	-$485.5M-215.4%	-$154.0M+62.5%	-$410.7M-35.2%	-$303.8M-152.7%	$576.3M+982.3%	-$65.3M-130.8%	$212.3M-33.6%	$319.8M+74.0%	$183.8M+126.1%	$81.3M
Dividends Paid	$795.0M	$780.4M+13.9%	$685.4M+6.5%	$643.9M+1.7%	$632.9M-0.7%	$637.6M+4.1%	$612.3M+8.5%	$564.1M+6.7%	$528.7M+5.2%	$502.6M+10.9%	$453.2M+26.5%	$358.2M+38.6%	$258.5M+18.5%	$218.1M+19.7%	$182.2M+12.5%	$161.9M
Share Buybacks	N/A	N/A	N/A	N/A	$142.3M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$2.9M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$217.7M-9.0%	$215.5M+18.4%	$230.6M+0.7%	$226.7M+22.6%	$239.3M+30.0%	$182.0M+20.1%	$229.0M+38.8%	$184.9M+8.1%
Depreciation & Amortization	$81.8M+1.7%	$84.1M+5.3%	$82.7M+5.3%	$82.1M+6.3%	$80.5M+8.5%	$79.9M+7.1%	$78.6M+3.9%	$77.2M-4.4%
Stock-Based Compensation	$23.5M+154.0%	$10.6M-33.0%	N/A	$9.3M+2.1%	$9.2M+0.5%	$15.8M+71.4%	N/A	$9.1M+3.7%
Investing Cash Flow	$552.1M+219.1%	-$270.0M-1501.9%	-$11.7M+95.8%	-$83.8M+37.2%	-$463.5M-122.3%	$19.3M+140.6%	-$281.7M-353.1%	-$133.5M-283.9%
Financing Cash Flow	-$639.1M-208.5%	$54.3M+115.6%	-$940.5M-486.4%	-$139.1M-151.9%	$589.0M+296.8%	-$347.7M-86.9%	$243.4M+162.4%	$268.1M+740.9%
Dividends Paid	$200.0M+2.8%	$198.4M+4.9%	$198.4M+9.3%	$198.2M+14.4%	$194.6M+17.2%	$189.2M+14.8%	$181.4M+10.3%	$173.3M+5.3%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.

OHI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OHI quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	59.4%+3.0pp	56.4%+21.7pp	34.7%-27.5pp	62.2%	N/A	N/A	N/A	N/A	N/A
Net Margin	0.1%0.0pp	0.0%0.0pp	0.0%0.0pp	0.1%0.0pp	0.0%-18.3pp	18.3%-19.6pp	37.9%+4.6pp	33.3%+21.8pp	11.6%-31.0pp	42.6%	N/A	N/A	N/A	N/A	N/A
Return on Equity	0.0%0.0pp	0.0%0.0pp	0.0%0.0pp	0.0%0.0pp	0.0%-4.3pp	4.3%-4.3pp	8.5%0.0pp	8.5%+5.6pp	2.9%-7.0pp	9.9%+3.7pp	6.2%-9.6pp	15.8%+2.5pp	13.3%+1.3pp	11.9%+5.9pp	6.0%
Return on Assets	0.0%0.0pp	0.0%0.0pp	0.0%0.0pp	0.0%0.0pp	0.0%-1.7pp	1.7%-1.9pp	3.6%+0.2pp	3.4%+2.2pp	1.2%-3.1pp	4.3%+1.4pp	2.9%-2.7pp	5.6%+0.7pp	5.0%+0.9pp	4.0%+2.0pp	2.1%
Debt-to-Equity	0.82-0.2x	1.07-0.4x	1.420.0x	1.46+0.1x	1.340.0x	1.35+0.1x	1.24-0.1x	1.320.0x	1.29+0.2x	1.13+0.2x	0.95-0.7x	1.70+0.1x	1.56-0.2x	1.800.0x	1.77
Asset Turnover	0.120.0x	0.110.0x	0.100.0x	0.090.0x	0.110.0x	0.090.0x	0.090.0x	0.100.0x	0.100.0x	0.10	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	100.8%	N/A	N/A	N/A	99.6%	N/A	N/A	N/A
Net Margin	110.5%	46.8%+7.4pp	-133.1%	57.7%+17.2pp	48.4%+3.3pp	39.4%+11.7pp	-104.7%	40.5%+1.7pp
Return on Equity	6.7%+4.0pp	2.9%+0.6pp	-8.2%-1.7pp	3.6%+0.9pp	2.7%-0.3pp	2.3%+0.4pp	-6.4%-1.1pp	2.7%+0.1pp
Return on Assets	3.6%+2.3pp	1.5%+0.4pp	-4.2%-1.3pp	1.7%+0.5pp	1.3%0.0pp	1.1%+0.4pp	-3.0%-0.9pp	1.2%+0.2pp
Debt-to-Equity	0.81-0.2x	0.920.0x	0.82-0.2x	0.99-0.2x	1.00-0.3x	0.94-0.5x	1.07-0.4x	1.15-0.3x
Asset Turnover	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x

Not reported in any period shown, so not listed: Gross Margin, Current Ratio, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Omega Healthcare Investors Inc. OHI	FY2025	$1.2B	$609K	0.1%	$13.5B	26/100
Healthpeak Properties, Inc. DOC	FY2025	$2.8B	$71.3M	2.5%	$13.0B	34/100
Ventas, Inc. VTR	FY2025	$5.8B	$261.5M	4.5%	$42.1B	33/100
CareTrust REIT, Inc CTRE	FY2025	$476.4M	$320.5M	67.3%	$8.5B	58/100
American Healthcare REIT, Inc. AHR	FY2025	$2.3B	$70.8M	3.1%	$11.1B	52/100
Welltower Inc. WELL	FY2025	$10.8B	$936.8M	8.6%	$162.5B	42/100

Where Omega Healthcare Investors Inc. Ranks

Frequently Asked Questions

What is Omega Healthcare Investors Inc.'s annual revenue?

Omega Healthcare Investors Inc. (OHI) reported $1.2B in total revenue for fiscal year 2025. This represents a 13.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Omega Healthcare Investors Inc.'s revenue growing?

Omega Healthcare Investors Inc. (OHI) revenue grew by 13.2% year-over-year, from $1.1B to $1.2B in fiscal year 2025.

Is Omega Healthcare Investors Inc. profitable?

Yes, Omega Healthcare Investors Inc. (OHI) reported a net income of $609K in fiscal year 2025, with a net profit margin of 0.1%.

How much debt does Omega Healthcare Investors Inc. have?

As of fiscal year 2025, Omega Healthcare Investors Inc. (OHI) had $27.0M in cash and equivalents against $4.3B in long-term debt.

What is Omega Healthcare Investors Inc.'s net profit margin?

Omega Healthcare Investors Inc. (OHI) had a net profit margin of 0.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Omega Healthcare Investors Inc. pay dividends?

Yes, Omega Healthcare Investors Inc. (OHI) paid $2.68 per share in dividends during fiscal year 2025.

What is Omega Healthcare Investors Inc.'s return on equity (ROE)?

Omega Healthcare Investors Inc. (OHI) has a return on equity of 0.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Omega Healthcare Investors Inc.'s operating cash flow?

Omega Healthcare Investors Inc. (OHI) generated $878.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Omega Healthcare Investors Inc.'s total assets?

Omega Healthcare Investors Inc. (OHI) had $10.0B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Omega Healthcare Investors Inc. have outstanding?

Omega Healthcare Investors Inc. (OHI) had 296M shares outstanding as of fiscal year 2025.

What is Omega Healthcare Investors Inc.'s debt-to-equity ratio?

Omega Healthcare Investors Inc. (OHI) had a debt-to-equity ratio of 0.82 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Omega Healthcare Investors Inc.'s return on assets (ROA)?

Omega Healthcare Investors Inc. (OHI) had a return on assets of 0.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Omega Healthcare Investors Inc.'s P/E ratio?

Omega Healthcare Investors Inc. (OHI) trades at 50.1x earnings, its market capitalization divided by net income of $268.9M net income, trailing 12 months to June 30, 2026. The market capitalization is $13.5B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Omega Healthcare Investors Inc.'s price-to-sales ratio?

Omega Healthcare Investors Inc. (OHI) trades at 10.5x sales, its market capitalization divided by revenue of $1.3B revenue, trailing 12 months to June 30, 2026. The market capitalization is $13.5B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Omega Healthcare Investors Inc.'s Piotroski F-Score?

Omega Healthcare Investors Inc. (OHI) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Omega Healthcare Investors Inc.'s earnings high quality?

Omega Healthcare Investors Inc. (OHI) reported $609K of net income while generating $878.6M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Omega Healthcare Investors Inc.?

Omega Healthcare Investors Inc. (OHI) scores 26 out of 100 on our Financial Health Score, indicating weak standing within its REITs peer group. The score is a 0-100 composite of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.